IL162766A0 - Phenylpyrimidine amines as ige inhibitors - Google Patents

Phenylpyrimidine amines as ige inhibitors

Info

Publication number
IL162766A0
IL162766A0 IL16276603A IL16276603A IL162766A0 IL 162766 A0 IL162766 A0 IL 162766A0 IL 16276603 A IL16276603 A IL 16276603A IL 16276603 A IL16276603 A IL 16276603A IL 162766 A0 IL162766 A0 IL 162766A0
Authority
IL
Israel
Prior art keywords
phenylpyrimidine
amines
ige inhibitors
ige
inhibitors
Prior art date
Application number
IL16276603A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0202381A external-priority patent/GB0202381D0/en
Priority claimed from GB0221953A external-priority patent/GB0221953D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL162766A0 publication Critical patent/IL162766A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16276603A 2002-02-01 2003-01-31 Phenylpyrimidine amines as ige inhibitors IL162766A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0202381A GB0202381D0 (en) 2002-02-01 2002-02-01 Organic compounds
GB0221953A GB0221953D0 (en) 2002-09-20 2002-09-20 Organic compounds
PCT/EP2003/000973 WO2003063871A1 (en) 2002-02-01 2003-01-31 Phenylpyrimidine amines as ige inhibitors

Publications (1)

Publication Number Publication Date
IL162766A0 true IL162766A0 (en) 2005-11-20

Family

ID=27665364

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16276603A IL162766A0 (en) 2002-02-01 2003-01-31 Phenylpyrimidine amines as ige inhibitors

Country Status (23)

Country Link
US (2) US20050119255A1 (pt)
EP (1) EP1474146B1 (pt)
JP (1) JP4393198B2 (pt)
KR (1) KR20040081159A (pt)
CN (2) CN1622807A (pt)
AR (1) AR038368A1 (pt)
AT (1) ATE406165T1 (pt)
AU (1) AU2003206810B2 (pt)
BR (1) BR0307379A (pt)
CA (1) CA2471883C (pt)
DE (1) DE60323205D1 (pt)
EC (1) ECSP045213A (pt)
ES (1) ES2312749T3 (pt)
IL (1) IL162766A0 (pt)
MX (1) MXPA04007395A (pt)
NO (1) NO20043610L (pt)
NZ (1) NZ534229A (pt)
PE (1) PE20030983A1 (pt)
PL (1) PL370666A1 (pt)
PT (1) PT1474146E (pt)
RU (1) RU2004126614A (pt)
TW (1) TW200302728A (pt)
WO (1) WO2003063871A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050014753A1 (en) * 2003-04-04 2005-01-20 Irm Llc Novel compounds and compositions as protein kinase inhibitors
EP1648875A1 (en) * 2003-07-30 2006-04-26 Cyclacel Limited 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
JPWO2005040135A1 (ja) * 2003-10-24 2007-03-08 小野薬品工業株式会社 抗ストレス薬およびその医薬用途
WO2007039216A1 (en) 2005-09-29 2007-04-12 Novartis Ag Phenyl-(4-phenyl-pyrimidin-2-yl)-amines for enhancing immunotolerance
WO2009023193A1 (en) * 2007-08-15 2009-02-19 Cytokinetics, Incorporated Certain chemical entities, compositions, and methods
KR20220150280A (ko) 2019-12-20 2022-11-10 이케나 온콜로지, 인코포레이티드 E.g. 혈관신생 관련 또는 염증성 장애의 치료를 위한 아릴 탄화수소 수용체 (ahr) 작용제로서의 4-페닐-n-(페닐)티아졸-2-아민 유도체 및 관련 화합물

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1185039A (en) 1966-03-31 1970-03-18 Ici Ltd Pyrimidine Derivatives and Compositions containing them
GB2001069B (en) 1977-07-12 1982-01-20 Scras Pyrimidine derivatives
AU5319479A (en) 1978-12-22 1980-06-26 Ici Australia Limited Pyrimidinyl amino phenoxy carboxylate derivatives
US4351939A (en) 1980-10-16 1982-09-28 Mead Johnson & Company Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
EP0084194B1 (de) 1982-01-14 1986-04-30 MERCK PATENT GmbH Flüssigkristallmischungen
FR2536071B1 (fr) 1982-11-12 1986-07-11 Sanofi Sa Sels acides de 2-piperazinopyrimidine, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2547821B1 (fr) 1983-06-24 1985-12-06 Sanofi Sa Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant
US4659363A (en) 1983-07-25 1987-04-21 Ciba-Geigy Corporation N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof
EP0164204A1 (en) 1984-05-12 1985-12-11 FISONS plc Novel pharmaceutically useful pyrimidines
EP0172786B1 (de) 1984-06-25 1991-01-30 Ciba-Geigy Ag Pyrimidinderivate wirksam als Schädlingsbekämpfungsmittel
ES2087056T3 (es) 1986-01-13 1996-07-16 American Cyanamid Co 2-pirimidinaminas sustituidas en las posiciones 4, 5 y 6.
DE3614060A1 (de) 1986-04-23 1987-10-29 Schering Ag Pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
EP0254259A3 (en) 1986-07-21 1989-11-23 Otsuka Pharmaceutical Factory, Inc. P-aminophenol derivatives
EP0264348B1 (de) 1986-10-13 1993-12-15 Ciba-Geigy Ag Harnstoffe
US4826990A (en) 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
EP0337946B1 (de) 1988-04-12 1993-07-28 Ciba-Geigy Ag Harnstoffe
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
US4973690A (en) 1988-04-12 1990-11-27 Ciba-Geigy Corporation Novel ureas
JPH02308248A (ja) 1989-05-24 1990-12-21 Fuji Photo Film Co Ltd アミノピリミジン系色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料
US5521184A (en) 1992-04-03 1996-05-28 Ciba-Geigy Corporation Pyrimidine derivatives and processes for the preparation thereof
US5516775A (en) 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
EP0672041B1 (en) 1993-10-01 2001-11-14 Novartis AG Pharmacologically active pyridine derivatives and processes for the preparation thereof
ES2262137T3 (es) 1993-10-01 2006-11-16 Novartis Ag Derivados de pirimidinamina farmacologicamente activos y procedimientos para su preparacion.
AU693475B2 (en) 1993-10-01 1998-07-02 Novartis Ag Pyrimidineamine derivatives and processes for the preparation thereof
PL313973A1 (en) * 1993-10-12 1996-08-05 Du Pont Merck Pharma 1 n-alkyl-n-arylopyrimidin amines and their derivatives
ES2201112T3 (es) 1994-08-13 2004-03-16 Yuhan Corporation Nuevos derivados de pirimidina y procedimientos para su preparacion.
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
TW520362B (en) 1996-12-05 2003-02-11 Amgen Inc Substituted pyrimidine compounds and pharmaceutical composition comprising same
EP0976745B1 (en) * 1997-03-26 2003-08-13 Taisho Pharmaceutical Co., Ltd 4-tetrahydropyridylpyrimidine derivatives
IN188411B (pt) 1997-03-27 2002-09-21 Yuhan Corp
US6440965B1 (en) 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
WO1999035140A1 (en) * 1998-01-12 1999-07-15 Novartis Ag PYRIDINYLPYRIMIDINE AMINES AS IMMUNOGLOBULINE E (IgE) SYNTHESIS INHIBITORS
ID24959A (id) * 1998-01-28 2000-08-31 Shionogi & Co Senyawa-senyawa trisiklik yang baru
TR200002760T2 (tr) 1998-03-27 2000-12-21 Janssen Pharmaceutica N.V. HIV engelleyici pirimidin türevleri
TWI241298B (en) 1998-09-25 2005-10-11 Mitsubishi Chem Corp Pyrimidone derivatives
HUP0104171A3 (en) * 1998-11-17 2002-04-29 Ihara Chemical Ind Co Pyrimidinylbenzimidazole and triatinylbenzimidazole derivatives, intermediates and use as agricultura/horticultural fungicides
GB9828511D0 (en) 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
WO2000066595A1 (fr) 1999-04-28 2000-11-09 Institute Of Medicinal Molecular Design. Inc. Derives d'acides carboxyliques heterocycliques
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB0003224D0 (en) 2000-02-11 2000-04-05 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
JP4393198B2 (ja) 2010-01-06
WO2003063871A1 (en) 2003-08-07
DE60323205D1 (en) 2008-10-09
ES2312749T3 (es) 2009-03-01
ATE406165T1 (de) 2008-09-15
TW200302728A (en) 2003-08-16
JP2005516051A (ja) 2005-06-02
NO20043610L (no) 2004-10-05
CA2471883A1 (en) 2003-08-07
EP1474146A1 (en) 2004-11-10
AU2003206810B2 (en) 2006-06-29
NZ534229A (en) 2005-04-29
PE20030983A1 (es) 2004-01-26
BR0307379A (pt) 2004-12-28
RU2004126614A (ru) 2005-05-27
PT1474146E (pt) 2008-12-05
CN101684097A (zh) 2010-03-31
PL370666A1 (en) 2005-05-30
US20070281956A1 (en) 2007-12-06
AR038368A1 (es) 2005-01-12
KR20040081159A (ko) 2004-09-20
US7759357B2 (en) 2010-07-20
EP1474146B1 (en) 2008-08-27
MXPA04007395A (es) 2005-06-17
CN1622807A (zh) 2005-06-01
CA2471883C (en) 2010-12-07
US20050119255A1 (en) 2005-06-02
ECSP045213A (es) 2004-09-28

Similar Documents

Publication Publication Date Title
EG25482A (en) Inhibitors
HK1071360A1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
AU2003271566A8 (en) Pyrrolopyrazines as kinase inhibitors
PL373338A1 (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
TWI369354B (en) Cytokine inhibitors
PL373146A1 (en) Pyridazinone-derivatives as pde4 inhibitors
PL373649A1 (en) Kinase inhibitors
AU2003300832A8 (en) Nf-kappab inhibitors
IL174010A0 (en) Cytokine inhibitors
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
SI1569907T1 (sl) Na nikotinamidu osnovani kinazni inhibitorji
EP1551801A4 (en) NOVEL GAMMA-LACTAMES AS INHIBITORS OF BETA-SECRETASE
ZA200510319B (en) 6-arylamino-5-cyano-4-pyrimidinones as PDE9a inhibitors
EP1569633A4 (en) CA-IX SPECIFIC HEMMER
EP1558609A4 (en) KINASE INHIBITORS
EP1532133A4 (en) NF-: B INHIBITORS
ZA200707086B (en) Cytokine inhibitors
EP1570847A4 (en) PHOSPHODIESTERASE 10A HEMMER
EP1569907A4 (en) NICOTINAMIDE-BASED KINASE HEMMER
IL162766A0 (en) Phenylpyrimidine amines as ige inhibitors
AU2003224941A8 (en) Nf-kappab inhibitors
GB0206415D0 (en) Deracemisation of amines
AU2003300124A8 (en) Novel nucleoside transport inhibitors
AU2003242559A8 (en) Alkylaminosiloxanes as corrosion inhibitors
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors